Notably, heme oxygenase-1 (HO-1), one of the three distinct isoforms belonging to the heme oxygenase (HO) family, has emerged as a pivotal component in Nrf2-mediated mechanisms underlying tumor resistance to anticancer therapies [56,57]. This evidence concerns the gene NFE2L2 and neoplasm.